Jump to Main Content
- Tabaran, Flaviu A., et al. Show all 11 Authors
- Biomaterials 2017 v.119 pp. 33-42
- albumins; ethics; hepatocytes; hepatoma; liver; models; nanogold; necrosis; neoplasm cells; patients; surgery
- ... We have used albumin (BSA) bound to gold nanoparticles (GNPs) as active vectors to target liver cells. Our incentive to develop an original model of living liver cancer sprang from the ethical drawbacks that hindered the assessment of the selective character and the therapeutic capacity of these nano-biosystems in cancer patients. Ex vivo-perfused liver specimens were obtained from hepatocellular ...